Defy VC

VC Menlo Park, United States · Founded 2016

Defy VC invests in early-stage companies, primarily at the Seed and Series A stages, focusing on ambitious founders building transformative businesses. They look for companies with strong teams and significant market opportunities across various sectors, including healthcare and enterprise software.

About Defy VC

Defy VC, also known as Defy Partners, is a Silicon Valley early-stage venture capital firm founded by experienced operator-investors, with a thesis focused on backing founder-operators building category-defining companies at seed and Series A. The firm has an active website, LinkedIn, Twitter, and Crunchbase presence, and has historically invested across enterprise software, consumer, fintech, and selective healthcare technology, with healthcare exposure that includes digital health and healthcare workflow software rather than therapeutics or devices. Check sizes typically range from $1M to $5M at seed and Series A, with the firm capable of leading rounds and bringing meaningful operator-network value. For healthcare AI founders, Defy is a credible potential lead if you are building software-style healthcare AI with strong founder-operator credentials, capital-efficient unit economics, and a clear path to commercial scale through enterprise or provider sales. The strongest fit is for founders with prior operating experience at well-known technology companies who are building applied AI for healthcare workflows, revenue cycle, clinical decision support, or adjacent enterprise healthcare problems. Founders building biotech, regulated diagnostics, capital-intensive devices, or care delivery models requiring payer contracting and risk-bearing will likely find Defy a non-fit. The firm’s value-add is most credible around go-to-market discipline, founder coaching, and connecting to the broader Silicon Valley operator and capital network. Entry path is warm referral from a portfolio CEO, LinkedIn outreach to the partners, or Twitter engagement. Founders should come ready to discuss founder background, market category framing, and a sharp narrative about why now and why this team.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Defy VC

Tools made by companies in Defy VC's portfolio that we cover in the directory.

Abridge
Abridge
Clinical Decision Support & Reference
Abridge is an enterprise-grade AI platform that transforms patient-clinician conversations into contextually aware, clinically useful, and billable AI-generated notes, integrating real-time clinical evidence and supporting various healthcare workflows. It is trusted by over 250 health systems and is HIPAA compliant and SOC 2 Type II certified.
WellSky SkySense AI
WellSky
Clinical Decision Support & Reference
WellSky SkySense AI offers a suite of AI-powered tools embedded in their EHRs, including ambient listening and transcription, AI-powered extraction for medication reconciliation and referrals, and clinical summaries.

Portfolio companies in our directory

Other portfolio companies

Companies in Defy VC's portfolio not currently in our directory.

Team

Neil Sequeira
Co-Founder & Partner
LinkedIn
Lauren Kolodny
Co-Founder & Partner
LinkedIn
Brian Stansky
Partner
LinkedIn
Madison Bell
Partner
LinkedIn
Rick Yang
Partner
LinkedIn
Niki Pezeshki
Partner
LinkedIn

Pitch / review this investor

Have you raised from Defy VC? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.